Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

Psychopharmacology

Volumn 183, Issue 1, 2005, Pages 118-126

  Beardsley, Patrick M ^a   Howard, James L ^b   Shelton, Keith L ^a   Carroll, F Ivy ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Antidepressant; Cocaine; Diuresis; Forced swim test; JDTic; Kappa; Nor binaltorphimine; Opioid; Rats; Reinstatement; Self administration; Stress

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 7 HYDROXY N [1 [[4 (3 HYDROXYPHENYL) 3,4 DIMETHYL 1 PIPERIDINYL]METHYL] 2 METHYLPROPYL] 1,2,3,4 TETRAHYDRO 3 ISOQUINOLINECARBOXAMIDE; ANTIDEPRESSANT AGENT; COCAINE; DESIPRAMINE; KAPPA OPIATE RECEPTOR ANTAGONIST; NORBINALTORPHIMINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CLIMBING; COCAINE DEPENDENCE; CONTROLLED STUDY; DIURESIS; DRUG EFFECT; DRUG POTENCY; DRUG SELECTIVITY; FORCED SWIMMING TEST; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE UPTAKE INHIBITORS; ELECTROSHOCK; FOOT; MALE; MOTOR ACTIVITY; PIPERIDINES; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; RECURRENCE; SELF ADMINISTRATION; STRESS, PSYCHOLOGICAL; SWIMMING; TETRAHYDROISOQUINOLINES;

EID: 26944494536     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0167-4     Document Type: Article

References (45)

1. Adamson WT, Windh RT, Blackford S, Kuhn CM (1991) Ontogeny of mu- and kappa-opiate receptor control of the hypothalamopituitary-adrenal axis in rats. Endocrinology 129:959-964
2. Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R (1996) The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro. J Neuroendocrinol 8:579-585
3. Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS (2004) Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol 501:111-119
4. Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66-72
5. Di Chiara G (1995) The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38:95-137
6. Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080
7. Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry 43:107-113
8. Goeders NE (2002) Stress and cocaine addiction. J Pharmacol Exp Ther 301:785-789
9. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J (2002) Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry 59:375-380
10. Iyengar S, Kim HS, Wood PL (1986) Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat. J Pharmacol Exp Ther 238:429-436
11. Katoh A, Nabeshima T, Kameyama T (1990) Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions. J Pharmacol Exp Ther 253:600-607
12. Kelly PH, Iversen SD (1976) Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45-56
13. Kreek MJ (1987) Multiple drug abuse patterns and medical consequences. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 1597-1604
14. Kreek MJ, Koob GF (1998) Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51:23-47
15. Leander JD (1983) A kappa opioid effect: increased urination in the rat. J Pharmacol Exp Ther 224:89-94
16. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, Jones RM, Portoghese PS, Carlezon WA Jr (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323-330
17. Maisonneuve IM, Archer S, Glick SD (1994) U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett 181:57-60
18. McLaughlin JP, Marton-Popovici M, Chavkin C (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23:5674-5683
19. McLaughlin JP, Ippolito D, Pintar JE, Chavkin C (2004) Kappa opioid receptor activation is necessary and sufficient to mediate the stress-induced potentiation of the cocaine CPP response. Society for Neuroscience 34th annual meeting, San Diego, 23-27 October 2004
20. McMahon RC (2001) Personality, stress, and social support in cocaine relapse prediction. J Subst Abuse Treat 21:77-87
21. Menendez L, Andres-Trelles F, Hidalgo A, Baamonde A (1993) Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice. Brain Res 611:264-271
22. Nabeshima T, Katoh A, Wada M, Kameyama T (1992) Stress-induced changes in brain Met-enkephalin, Leu-enkephalin and dynorphin concentrations. Life Sci 51:211-217
23. Newton SS, Thome J, Wallace TL, Shirayama Y, Schlesinger L, Sakai N, Chen J, Neve R, Nestler EJ, Duman RS (2002) Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 22:10883-10890
24. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr (2001) Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 21:7397-7403
25. Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730-732
26. Przewlocki R, Lason W, Hollt V, Silberring J, Herz A (1987) The influence of chronic stress on multiple opioid peptide systems in the rat: pronounced effects upon dynorphin in spinal cord. Brain Res 413:213-219
27. Reith ME, Sershen H, Lajtha A (1980) Saturable (3H)cocaine binding in central nervous system of mouse. Life Sci 27:1055-1062
28. Reith ME, Sershen H, Allen DL, Lajtha A (1983) A portion of [3H] cocaine binding in brain is associated with serotonergic neurons. Mol Pharmacol 23:600-666
29. Schenk S, Partridge B (2001) Effect of the kappa-opioid receptor agonist, U69593, on reinstatement of extinguished amphetamine self-administration behavior. Pharmacol Biochem Behav 68:629-634
30. Schenk S, Partridge B, Shippenberg TS (1999) U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology (Berl) 144:339-346
31. Schenk S, Partridge B, Shippenberg TS (2000) Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593. Psychopharmacology (Berl) 151:85-90
32. Sershen H, Reith ME, Hashim A, Lajtha A (1984) Reduction of dopamine uptake and cocaine binding in mouse striatum by N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Eur J Pharmacol 102:175-178
33. Shelton KL, Beardsley PM (2005) Interaction of extinguished cocaine-conditioned stimuli and footshock on reinstatement. Int J Comp Psychol 18:154-166
34. Shelton KL, Hendrick E, Beardsley PM (2004) Interaction of noncontingent cocaine and contingent drug-paired stimuli on cocaine reinstatement. Eur J Pharmacol 497:35-40
35. Shirayama Y, Ishida H, Iwata M, Hazama GI, Kawahara R, Duman RS (2004) Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90:1258-1268
36. Sinha R, Fuse T, Aubin LR, O'Malley SS (2000) Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl) 152:140-148
37. Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ (2003) Hypothalamic-pituitary-adrenal axis and sympathoadreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) 170:62-72
38. Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734-1740
39. Takahashi M, Senda T, Tokuyama S, Kaneto H (1990) Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia. Jpn J Pharmacol 53:487-494
40. Thomas JB, Atkinson RN, Rothman RB, Fix SE, Mascarella SW, Vinson NA, Xu H, Dersch CM, Lu Y, Cantrell BE, Zimmerman DM, Carroll FI (2001) Identification of the first trans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. J Med Chem 44:2687-2690
41. Thomas JB, Atkinson RN, Vinson NA, Catanzaro JL, Perretta CL, Fix SE, Mascarella SW, Rothman RB, Xu H, Dersch CM, Cantrell BE, Zimmerman DM, Carroll FI (2003) Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3- hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3, 4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist. J Med Chem 46: 3127-3137
42. Thomas JB, Fix SE, Rothman RB, Mascarella SW, Dersch CM, Cantrell BE, Zimmerman DM, Carroll FI (2004) Importance of phenolic address groups in opioid kappa receptor selective antagonists. J Med Chem 47:1070-1073
43. Werling LL, Frattali A, Portoghese PS, Takemori AE, Cox BM (1988) Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J Pharmacol Exp Ther 246:282-286
44. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492
45. You ZB, Herrera-Marschitz M, Terenius L (1999) Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides. J Pharmacol Exp Ther 290:1307-1315